The Patent Finder

Angstrom Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Angstrom Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Angstrom Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,697,629Modulation of intracellular signaling
Lapsed on the fee record
Ended Apr 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 15, 2026From the USPTO record
US 8,313,914Compositions and methods for modulation of cell migration
Lapsed on the fee record
Ended Nov 20, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 20, 2024From the USPTO record
US 7,807,621Anti-invasive and anti-angiogenic compositions
Lapsed on the fee record
Ended Oct 5, 2018 · From the USPTO record
Lapsed on the fee recordEnded Oct 5, 2018From the USPTO record
US 6,696,416Anti-invasive and anti-angiogenic compositions
Term ended
Term ended Jul 25, 2017 · From the USPTO record
Term endedTerm ended Jul 25, 2017From the USPTO record
US 6,936,587Anti-invasive and anti-angiogenic compositions
Term ended
Ended no later than Jul 25, 2017 · From the USPTO record
Term endedEnded no later than Jul 25, 2017From the USPTO record
US 8,110,543Anti-invasive and anti-angiogenic compositions
Term ended
Term ended Jul 25, 2017 · From the USPTO record
Term endedTerm ended Jul 25, 2017From the USPTO record
US 6,514,710Method of using cyclic peptides to inhibit binding to urokinase-type plasminogen activator receptor
Lapsed on the fee record
Ended Feb 4, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 4, 2015From the USPTO record
US 6,277,818Cyclic peptide ligands that target urokinase plasminogen activator receptor
Lapsed on the fee record
Ended Aug 21, 2013 · From the USPTO record
Lapsed on the fee recordEnded Aug 21, 2013From the USPTO record
US 6,896,870Diagnostic probes and therapeutics targeting uPA and uPAR
Lapsed on the fee record
Ended May 24, 2013 · From the USPTO record
Lapsed on the fee recordEnded May 24, 2013From the USPTO record
US 5,942,492Cyclic peptides that bind to urokinase-type plasminogen activator receptor
Term ended
Term ended no later than Aug 24, 2019 · Low confidence
Term endedTerm ended no later than Aug 24, 2019Low confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited